Executive Director PO&T Asset Management

We are looking for an experienced and strategic leader to join our Pharmaceutical Operations & Technologies organization as

Executive Director PO&T Asset Management.

In this role, you will help translate business and functional strategies into clear priorities and an integrated portfolio of

high-impact initiatives. You will work closely with senior leaders across Pharmaceutical Operations, Technology, Manufacturing,

Quality, Supply Chain, Regulatory and Finance to ensure that strategic initiatives are effectively prioritized, resourced,

governed and executed.

• Provide input to the strategic roadmap for Pharmaceutical Operations & Technologies in alignment with overall company

objectives.

• Translate corporate and functional strategies into actionable priorities, programs, and measurable outcomes for PO&T by

project.

• Provide executive-level recommendations regarding priorities, resource allocation, investments, risks, and organizational

capabilities.

• Oversee a portfolio of complex, cross-functional programs from strategy and business case development through implementation

and benefits realization for PO&T.

• Ensure projects are appropriately prioritized based on strategic value, business impact, risk, complexity, and resource

requirements for PO&T.

• Lead strategic transformation initiatives designed to improve pharmaceutical operations, organizational effectiveness,

technology capabilities, and business performance.

• Partner with technology and business leaders to develop technology strategies that support operational and strategic objectives

for PO&T.

• Ensure transformation initiatives deliver measurable improvements in efficiency, quality, compliance, scalability, and business

value for PO&T.

• Ensure strategic PO&T initiatives operate within applicable pharmaceutical, regulatory, quality, compliance, cybersecurity, and

corporate governance requirements.

• 15+ years of experience in pharmaceutical, biotechnology, life sciences, healthcare, technology, operations, or a related

industry.

As a global organization, we are open to considering candidates in multiple locations. The position can be based either at our

Stockholm, Sweden office or at our Cary, North Carolina office, depending on the selected candidate and the position reports to

the Senior Vice President and Head of Pharmaceutical Operations & Technologies.

The Asahi Kasei Group operates with a commitment of creating for tomorrow. Our business sectors, Material, Homes, and Health Care,

contribute to the development of society by anticipating the changing needs of those around the world. We look for candidates that

offer a fresh perspective and a variety of skills to help us achieve our commitment.

Calliditas’ lead product, developed under the name Nefecon, has received full approval by the FDA under the trade name TARPEYO®

and by the European Commission under the trade name KINPEYGO®. TARPEYO/KINPEYGO® is the first treatment approved for IgA

nephropathy by the FDA and EMA, respectively.